✦ LIBER ✦

Statin therapy for the treatment of diabetic dyslipidemia

✍ Scribed by Steven M. Haffner

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 116 KB
Volume: 19
Category: Article
ISSN: 1520-7552
DOI: 10.1002/dmrr.393

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New therapies available for the treatmen

New therapies available for the treatment of type 2 diabetes

✍ C Day 📂 Article 📅 2006 🏛 Maney Publishing 🌐 English ⚖ 371 KB 👁 1 views

New therapies for the treatment of type

New therapies for the treatment of type 2 diabetes: an update

✍ C Day 📂 Article 📅 2009 🏛 Maney Publishing 🌐 English ⚖ 377 KB 👁 1 views

Hyperbaric oxygen therapy as treatment o

Hyperbaric oxygen therapy as treatment of diabetic foot ulcers

✍ Magnus Löndahl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 1 views

Statins and Fibrates in the Management o

Statins and Fibrates in the Management of Diabetic Dyslipidaemia

✍ Durrington, P. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 3 views

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Surgical treatment of the diabetic foot

✍ E. Ruth Chaytor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 2 views